ARCHIVES

Funding Opportunities: NIAID seeks New Investigator, Risky Research Proposals

This article is from The Cancer Letter archive.

Vol. 23 No. 12 | March 28, 1997

Download PDF Visit The Full Archive

Related Articles

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

March 30, 2001

FDA Committee Approves NDA for Mitxantrone

March 21, 1986

In Brief: NCI Grants Get More Money, Pay Line Boosted To 193

May 22, 1981

Study: Oncotype DX Score Can Predict Local Recurrence

March 29, 2013

In Brief: Friedman Leads FDA During Search; Mead Retires From NCI; Freireich Honored

March 14, 1997

FDA Approves Cyramza for Stomach Cancer; Zykadia in NSCLC; Lipiodol for HCC Imaging; And Cobas HPV Test for Primary Screening

April 25, 2014